Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin Chronotherapy for Hypertension
NCT00449618Phase 4Terminated
- Sponsor
- Universidade de Vigo
- Start
- Jan 2007
- Primary completion
- Dec 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of aspirin in essential hypertension and prehypertension (3 arms), sponsored by Universidade de Vigo. Primary endpoint: 24-hour Systolic Blood Pressure at 14 weeks. Started Jan 2007; status: terminated.
02
Drugs
aspirin
03
Conditions
essential hypertensionprehypertension
Beyond the preview
Go deeper on NCT00449618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00449618.